
AustinPx™: Revolutionizing pharma with KinetiSol™ tech, simplifying drug development and manufacturing.
AustinPx™, Pharmaceutics and Manufacturing, was founded to help pharmaceutical developers realize the full potential of their drug candidates by overcoming obstacles such as poor bioavailability and accelerated timelines. The company offers a client-centric approach to simplify the complexities of outsourcing, providing formulation, analytical, and manufacturing expertise. AustinPx's core mission is to revolutionize pharma with its proprietary KinetiSol™ technology, aiming to streamline drug development and manufacturing processes.
Notable affiliated people and investors include experts in formulation, analytical, and manufacturing fields, although specific names are not disclosed. Key achievements of AustinPx include the successful implementation of KinetiSol™ technology in various drug development projects, significantly enhancing drug bioavailability and reducing time-to-market. The overall impact of AustinPx has been substantial in the pharmaceutical industry, enabling faster and more efficient drug development and manufacturing for its clients.

August Bioservices
augustbio.com

Forma
formatech.com

Aether Therapeutics

Astatech
astatechinc.com

Auxilius Pharma
auxiliuspharma.com

Axikin Pharmaceuticals

Pharmapotheca A
chemapotheca.com

Ascendia Pharmaceuticals
ascendiapharma.com

Societal Cdmo
societalcdmo.com

Qnovia
qnovia.com

Agile Sciences
agilesci.com

Qatch Technologies
qatchtech.com

Concours Pharmaceuticals

Akelos
akelosinc.com
Kalypsys
kalypsys.com
Companies similar to AustinPx include August Bioservices, Forma, Aether Therapeutics and Astatech.
AustinPx was founded in 2007.
AustinPx's headquarters is located in Georgetown, TX, US.
AustinPx's most recent funding round was for $4.7M (USD) in October 2020.
As of Oct 16, 2020, AustinPx has raised a total of $58M (USD).
AustinPx has 69 employees as of Feb 4, 2024.